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The number of radiofrequency catheter ablation (RFA)
procedures performed in the epicardial space is increasing.1
Major acute complications (primarily pericardial bleeding)
and delayed complications have been reported in 5% and 2%
of cases, respectively.2–4 To the best of our knowledge, a
single case of constrictive pericarditis after multiple epicar-
dial ablations for ventricular tachycardia has been reported.5
We describe a late presentation of constrictive pericarditis
that occurred after a single percutaneous epicardial
procedure with limited ablation for inappropriate sinus
tachycardia.
Case report
A 52-year-old man with asthma developed palpitations and,
after extensive evaluation, was diagnosed with inappropriate
sinus tachycardia. Palpitations were refractory to diltiazem
and ﬂecainide therapy, and ivabradine was unavailable. He
underwent an electrophysiology study and endocardial
activation mapping. RFA of the sinus node region was
incomplete owing to proximity to the phrenic nerve. His
symptoms became disabling and therefore, he underwent an
endocardial-epicardial ablation 3 months later.
Uncomplicated percutaneous subxyphoid epicardial
access was obtained with a Tuohy needle as described by
Sosa et al.6 An 8F sheath was advanced over the wire and a
second long wire (Wholey) was advanced into the same
sheath to implement a double wire technique. A peripheral
angioplasty balloon was placed through a deﬂectable sheath
(Agilis; St Jude Medical, Minneapolis, MN) to displace the
phrenic nerve, and the RFA catheter was advanced to the
right atrium (Figure 1). Radiofrequency energy using aKEYWORDS Inappropriate sinus tachycardia; Catheter ablation; Pericardial
disease; Magnetic resonance imaging; Pericardial constriction
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CA) was delivered in the endocardium. The ablation catheter
and the angioplasty balloon were both removed and the
ablation catheter was inserted into the epicardial space
through the deﬂectable sheath, and 5 focal lesions were
delivered in the epicardium overlying the sinus node. At the
end of the procedure his heart rate decreased from 140 to 70
beats per minute. Kenalog (1 mg/kg) was injected into the
pericardial space and the epicardial sheath was removed
immediately after the procedure. The ﬂuid was serous,
without any evidence of bleeding, throughout the case.
Twelve hours after the procedure, the patient developed
pleuritic chest pain, treated with indomethacin, colchicine,
and his home dose of aspirin 81 mg daily. New diffuse ST-
segment elevations were noted on electrocardiogram, con-
sistent with acute pericarditis (Figure 2). An echocardiogram
showed no effusion. His chest pain resolved in 48 hours and
he was discharged 3 days after the procedure. The indome-
thacin and colchicine were continued for 1 month.
He was seen in follow-up at 1, 3, and 6 months and with
resolution of his symptoms. No ST elevations or ﬁndings of
chronic pericarditis were noted on electrocardiograms at the
follow-up visits. Nine months after the epicardial ablation he
returned to the clinic with dyspnea on exertion, abdominal
ascites, weight gain, and lower-extremity edema requiring
increasing doses of oral bumetanide. The patient was
afebrile. Blood work demonstrated a normal white blood
cell count, a normal thyroid-stimulating hormone level, a
Westergren erythrocyte sedimentation rate of 27 mm/h
(upper limit of normal is 25 mm/h), a C-reactive protein of
16 mg/L (upper limit of normal iso5 mg/L), an antinuclear
antibody of 1:320 in a speckled pattern, and a negative anti–
double-stranded deoxyribonucleic acid titer. An echocardio-
gram revealed normal biventricular function and a stress test
showed a maximum workload of 6.3 metabolic equivalents
and a hypotensive response to peak exercise. A cardiac
magnetic resonance imaging study showed pericardial thick-
ening with concern for constrictive pericarditis (Figure 3). A
coronary angiogram and simultaneous left and right heartpen access article under the CC BY-NC-ND license
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KEY TEACHING POINTS
 Pericardial constriction should be included in the
differential diagnosis of new-onset congestive
heart failure after epicardial access and epicardial
ablation procedures.
 Pericardial constriction can occur with even small
amounts of delivered radiofrequency energy and a
single, uncomplicated epicardial access procedure.
 Intrapericardial steroid administration may reduce
the risk of pericarditis, but this ﬁnding has not
been conﬁrmed in human cases.
Heart Rhythm Case Reports, Vol 2, No 5, September 2016442catheterization demonstrated no coronary artery disease but
equalization of diastolic pressures, conﬁrming pericardial
constriction (Figure 4). He was taken to the operating room
and found to have severe global thickening of the posterior
pericardium and moderate thickening of the anterior peri-
cardium, and underwent an uncomplicated endoscopic
pericardiectomy. Surgical pathology demonstrated pericar-
dial ﬁbrosis with focal chronic inﬂammation, including
plasma cells (Figure 5). After surgery, his symptoms
improved and repeat magnetic resonance imaging demon-








Figure 1 Left anterior oblique ﬂuoroscopic image showing the inﬂated
angioplasty balloon in the epicardial space to increase the separation between
the endocardial ablation catheter and the phrenic nerve. CS¼ coronary sinus
catheter; ICE ¼ intracardiac echocardiography catheter.Discussion
This case illustrates that constrictive pericarditis can occur as
a late complication after a single percutaneous epicardial
ablation procedure and should be included in the differential
diagnosis of new-onset heart failure after epicardial ablation.
The severity and diffuse nature of the pericardial thickening
far exceeded the amount of radiofrequency energy delivered,
and it is likely that the patient developed a diffuse reactive
pericarditis. Given that using the angioplasty balloon to
isolate the phrenic nerve involves a physical displacement of
the heart, it is possible that this technique results in more
diffuse pericardial inﬂammation in a similar way to vessel
angioplasty.7,8
A previous occurrence of constrictive pericarditis following
endocardial atrial ﬁbrillation ablation has been reported, but the
causative relationship is less evident than in procedures with
direct pericardial instrumentation.9 The contribution of the
endocardial lesions to the pericarditis is uncertain. Given the
absence of symptoms for 6 months, it does not appear that he
had chronic clinical pericarditis. In the previously published
report by Javaheri et al,5 the development of constriction was
more probable, given the repeated instrumentation of the
pericardial space with 4 epicardial procedures.
Intrapericardial steroids were administered following the
procedure as a prophylactic measure. D’Avila et al10 dem-
onstrated in a porcine model that the administration of
triamcinolone prevented hemorrhagic pericarditis. The rele-
vance of these ﬁndings to human cases requires further
investigation. There are data from the cardiothoracic surgery
literature that prophylactic colchicine may reduce the inci-
dence of postpericardiotomy syndrome and therefore reduce
the incidence of postoperative pericarditis.11,12 Prophylactic
colchicine and systemic corticosteroids both reduce inﬂam-
matory markers after pulmonary vein isolation.13,14 How-
ever, the studies examining prophylactic colchicine did not
include pericarditis as an outcome and the prophylactic
steroid study had no episodes of pericarditis in either the
placebo or steroid groups.13,14 Therefore, it is unclear at this
time if there are any prophylactic pharmacologic options to
reduce postablation pericarditis. Certainly, additional studies
are needed.Conclusions
To the best of our knowledge, this is the ﬁrst case of
pericardial constriction after a single uncomplicated percuta-
neous epicardial procedure with ablation limited to the right
atrium. As epicardial procedures continue to evolve, it is
important to recognize this rare complication.
Figure 2 Electrocardiograms (ECGs). (A) ECG obtained the day after the procedure with diffuse ST-segment elevations in leads I, II, and V2–V6 with ST-
segment depression in aVR consistent with acute pericarditis. (B) ECG obtained at the 1-month follow-up visit, demonstrating resolution of the ST-segment
elevation.
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Figure 3 Cardiac magnetic resonance imaging (MRI). (A) Cardiac MRI late gadolinium imaging demonstrating circumferential enhancement of the
pericardium, consistent with constriction. (B) Postcontrast T1-weighted black blood image demonstrating thickening of pericardium 46 mm. (C) Follow-up
postoperative cardiac MRI with late gadolinium imaging showing decreased enhancement in the pericardium, demonstrating resolution of the constricted
pericardium.
Figure 4 Simultaneous left and right heart catheterization. (A) Simultaneous pulmonary capillary wedge (red) and right atrial (green) tracings demonstrating
the equalization of diastolic pressures and the rapid y descent. (B) Simultaneous left and right heart catheterization pressure tracings demonstrating equalization
of diastolic pressures and the classic dip and plateau. The red tracing is the left ventricle and the green tracing is the right ventricle.
Heart Rhythm Case Reports, Vol 2, No 5, September 2016444
Figure 5 Pericardial pathology. High-power photomicrograph of peri-
cardium shows ﬁbrosis, lymphocytes, plasma cells, and focal hemosiderin
deposits (hematoxylin-eosin stain).
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